Bottom line
How much do FBT and IBBQ overlap?
25% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 31.4% of FBT's assets and 29.6% of IBBQ's. They are substantially different portfolios, so owning both adds real diversification.
IBBQ holds far more positions (261 vs 32), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBT and IBBQ have in common
| Holding | % of FBT | % of IBBQ | Overlap |
|---|---|---|---|
| Illumina Inc ILMN | 3.92% | 1.98% | 1.98% |
| Neurocrine Biosciences Inc NBIX | 3.53% | 1.26% | 1.26% |
| Biogen Inc BIIB | 3.37% | 2.29% | 2.29% |
| Exelixis Inc EXEL | 3.32% | 1.04% | 1.04% |
| Incyte Corp INCY | 3.18% | 1.53% | 1.53% |
| Argenx Se ARGX | 3.13% | 1.89% | 1.89% |
| Vertex Pharmaceuticals Inc VRTX | 3.07% | 7.38% | 3.07% |
| Amgen Inc AMGN | 2.78% | 7.10% | 2.78% |
| United Therapeutics Corp UTHR | 2.56% | 1.94% | 1.94% |
| Alnylam Pharmaceuticals Inc ALNY | 2.52% | 3.19% | 2.52% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBT
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Krystal Biotech Inc — 3.87%
- Natera Inc — 3.79%
- Axsome Therapeutics Inc — 3.71%
- Bio-techne Corp — 3.43%
- Arrowhead Pharmaceuticals Inc — 3.38%
- Halozyme Therapeutics Inc — 3.11%
- Repligen Corp — 3.07%
- Biomarin Pharmaceutical Inc — 2.83%
- Biontech Se — 2.63%
- Genmab A/s — 2.62%
Only in IBBQ
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Revolution Medicines, Inc. — 2.48%
- Royalty Pharma PLC — 1.90%
- Insmed Inc. — 1.83%
- Roivant Sciences Ltd. — 1.71%
- Viatris Inc. — 1.49%
- Moderna, Inc. — 1.48%
- Guardant Health, Inc. — 1.35%
- Jazz Pharmaceuticals PLC — 1.16%
- Ascendis Pharma A/S — 1.10%
- Summit Therapeutics Inc. — 1.08%
- BridgeBio Pharma, Inc. — 1.02%
Asset mix
| Asset type | FBT | IBBQ |
|---|---|---|
| Stocks | 100.0% | 99.9% |
| Cash & short-term funds | 0.1% | 19.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | FBT | IBBQ |
|---|---|---|
| US | 85.0% | 103.8% |
| IE | 4.2% | 1.9% |
| NL | 3.1% | 2.5% |
| GB | — | 2.7% |
| DE | 2.6% | 0.9% |
| DK | 2.6% | 1.2% |
| CH | 2.5% | 1.2% |
| BM | — | 1.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FBT and IBBQ overlap?
What stocks do FBT and IBBQ have in common?
Should I own both FBT and IBBQ?
Which holds more stocks, FBT or IBBQ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.